Pediatric cancer mortality: Analyzing early deaths and fatalities in a resource-limited tertiary care context

Ahmed Farrag1,2, Amira Mahmoud Osman1, Mohamed Hamdy Ghazaly3

  • 1Pediatric Oncology and Hematological Malignancies Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.

Plos One
|October 28, 2024
PubMed

Insights

Delayed presentation and early deaths significantly impact childhood cancer survival. Improving early diagnosis and supportive care is crucial, especially for hematological malignancies, to enhance treatment outcomes.

Area of Science:

  • Pediatric Oncology
  • Cancer Epidemiology
  • Clinical Research

Background:

  • Childhood cancer patients face risks of rapid deterioration and death before diagnosis.
  • Delayed presentation and early mortality are critical challenges in pediatric oncology.
  • Understanding mortality patterns across different childhood cancer types is essential.

Purpose of the Study:

  • To investigate delayed presentation and early deaths in children with suspected cancer.
  • To analyze mortality types and causes in pediatric cancer patients.
  • To identify factors contributing to poor outcomes in childhood malignancies.

Main Methods:

  • Retrospective review of 502 pediatric oncology patients admitted between 2006-2010.
  • Analysis of patient demographics, diagnosis, symptoms, and time intervals (symptoms to visit, admission to death).
  • Categorization of mortality causes (treatment-related vs. disease-related) and specific causes (infection, respiratory failure, etc.).

Main Results:

  • 47.4% of patients (238/502) died; 66% of deaths were treatment-related mortality (TRM), primarily due to infection (60%).
  • Hematological malignancies had higher TRM (81%) compared to solid tumors (primarily disease-related, 70%).
  • Early death (<48 hours post-admission) occurred in 5% of patients; mean delay from symptom onset to first visit was 67 days.

Conclusions:

  • Delayed presentation significantly contributes to early deaths in pediatric cancer patients.
  • Enhanced early diagnosis and supportive care are vital for improving survival rates.
  • Specific attention to hematological malignancies is needed to reduce mortality.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
102
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
184
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
310